News & Insights

Gide’s Warsaw office advised KGHM Polska Miedź S.A., as the issuer, on issuing seven-year Series D bonds at a record low margin of 100 bps above the r...

Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associ...

Gide has advised a bank syndicate on a €5 billion notes issuance by Orange.The first of five tranches has a principal amount of €750 million with an a...

Gide advised a bank syndicate composed of Barclays Bank Ireland PLC, Crédit Agricole Corporate and Investment Bank, Mediobanca – Banca di Credito Fina...

Gide advises the banks’ syndicate, including Leerink Partners, Piper Sandler & Co. and Guggenheim Securities, as joint bookrunning managers, LifeS...

Gide advises the European Investment Bank (EIB) on a €37.5 million venture debt financing for MaaT Pharma, a French biotechnology company listed on Eu...

Gide has advised McPhy Energy, a leading industrial player in the hydrogen market, on the sale of its assets and operations to John Cockerill Hydrogen...

Gide has advised CNP Assurance on the inclusion of a Resticted Tier 1 option in its EMTN Programme as well as on the first issuance of €500 million su...

Gide’s Warsaw office assisted the State Treasury of the Republic of Poland, represented by the Minister of Finance, in connection with an offeri...

Gide advised the bank syndicate composed of BNP Paribas, Citigroup Global Markets Europe AG, Commerzbank Aktiengesellschaft, Crédit Agricole Corporate...